JP2011529936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011529936A5 JP2011529936A5 JP2011521529A JP2011521529A JP2011529936A5 JP 2011529936 A5 JP2011529936 A5 JP 2011529936A5 JP 2011521529 A JP2011521529 A JP 2011521529A JP 2011521529 A JP2011521529 A JP 2011521529A JP 2011529936 A5 JP2011529936 A5 JP 2011529936A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- dicarboxylic acid
- chitosan
- dicarboxylic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 20
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 6
- 229920001661 Chitosan Polymers 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 206010043189 Telangiectasia Diseases 0.000 claims 2
- 150000001991 dicarboxylic acids Chemical class 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims 2
- 208000009056 telangiectasis Diseases 0.000 claims 2
- 108010008488 Glycylglycine Proteins 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 241001303601 Rosacea Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- JQDCYGOHLMJDNA-UHFFFAOYSA-N bis(oxiran-2-ylmethyl) butanedioate Chemical compound C1OC1COC(=O)CCC(=O)OCC1CO1 JQDCYGOHLMJDNA-UHFFFAOYSA-N 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000000084 colloidal system Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 claims 1
- 229940054190 hydroxypropyl chitosan Drugs 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 210000003141 lower extremity Anatomy 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 1
- 201000004700 rosacea Diseases 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08161799A EP2116237A1 (en) | 2008-08-05 | 2008-08-05 | Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| EP08161799.5 | 2008-08-05 | ||
| PCT/EP2009/059749 WO2009150257A2 (en) | 2008-08-05 | 2009-07-28 | Compositions for treating rosacea |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011529936A JP2011529936A (ja) | 2011-12-15 |
| JP2011529936A5 true JP2011529936A5 (cg-RX-API-DMAC7.html) | 2012-05-17 |
| JP5646477B2 JP5646477B2 (ja) | 2014-12-24 |
Family
ID=40140031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011521529A Expired - Fee Related JP5646477B2 (ja) | 2008-08-05 | 2009-07-28 | キトサンおよびジカルボン酸を含む、酒さ疾患を治療するための組成物 |
Country Status (28)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2975004B1 (fr) | 2011-05-13 | 2013-06-28 | Expanscience Lab | Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant |
| US9023399B2 (en) | 2012-11-16 | 2015-05-05 | NU Technology, LLC | Water-soluble anti-inflammatory cream with natural ingredients base |
| US8613961B1 (en) | 2013-01-09 | 2013-12-24 | NU Technology, LLC | Dermatological cream with natural ingredients base |
| EP3233027B1 (en) | 2014-12-15 | 2021-10-13 | Unilever IP Holdings B.V. | Compositions for providing improved sunscreen protection |
| GB2600384A (en) | 2020-09-30 | 2022-05-04 | Vaderis Therapeutics Ag | Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4845204A (en) * | 1985-02-07 | 1989-07-04 | Wella Aktiengesellschaft | Cosmetic compositions on the basis of alkyl-hydroxypropyl-substituted chitosan derivatives, new chitosan derivatives and processes for the production thereof |
| DE3541305A1 (de) * | 1985-11-22 | 1987-05-27 | Wella Ag | Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung |
| DE3723811A1 (de) * | 1987-07-18 | 1989-01-26 | Wella Ag | Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans |
| JPH05339152A (ja) * | 1992-06-09 | 1993-12-21 | Nippon Soda Co Ltd | 皮膚病変局所投与薬剤含有キトサン誘導体フィルム剤 |
| EP0640643B1 (en) * | 1993-08-10 | 2000-04-26 | Kao Corporation | Organopolysiloxanes and a method of setting hair using the same |
| WO1998036730A2 (de) * | 1997-02-21 | 1998-08-27 | Beiersdorf Ag | Zubereitungen für die behandlung von rosacea |
| JP4185173B2 (ja) | 1997-08-07 | 2008-11-26 | 株式会社ノエビア | 両親媒性キトサン誘導体及びこれを含有する皮膚外用剤 |
| US6391334B1 (en) * | 1999-10-25 | 2002-05-21 | Amway Corporation | Barrier-forming composition |
| US6734210B2 (en) * | 2000-02-24 | 2004-05-11 | Rolland F. Hebert | Therapeutically improved salts of azelaic acid |
| US6451773B1 (en) * | 2000-03-31 | 2002-09-17 | Cognis Corporation | Chitosan formulation with azelaic acid and other actives for the treatment of acne |
| DE10035991A1 (de) * | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
| KR20020048534A (ko) | 2000-12-18 | 2002-06-24 | 안병로 | 파라핀 왁스를 유효성분으로 하는 피부 맛사지 팩제 |
| SE0100166D0 (sv) | 2001-01-22 | 2001-01-22 | Tacton Systems Ab | Configuration system |
| KR100457546B1 (ko) | 2001-05-02 | 2004-11-18 | 주식회사 바이오프로젠 | 폴리프럭토오스 또는 그 유도체를 이용한 미소구 및 그제조방법 |
| US6680062B2 (en) * | 2001-10-05 | 2004-01-20 | Color Access, Inc. | Anti-irritating rosacea treatment |
| GB0126923D0 (en) | 2001-11-09 | 2002-01-02 | Procter & Gamble | Chitosan compositions |
| US20030138467A1 (en) * | 2001-12-27 | 2003-07-24 | Avon Products, Inc. | Methods for improving the aesthetic appearance of skin |
| US20040081672A1 (en) | 2002-10-25 | 2004-04-29 | Gupta Shyam K. | Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging |
| WO2004068970A2 (en) * | 2003-01-31 | 2004-08-19 | The Procter & Gamble Company | Means for improving the appearance of mammalian keratinous tissue |
| JP2004231604A (ja) | 2003-01-31 | 2004-08-19 | Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai | 担体シートおよび徐放性製剤ならびにそれらの製法 |
| US20040156873A1 (en) * | 2003-02-10 | 2004-08-12 | Gupta Shyam K. | Topically Bioavailable Acne and Rosacea Treatment Compositions |
| US20040220264A1 (en) * | 2003-03-17 | 2004-11-04 | Yu Ruey J | Bioavailability and improved delivery of acidic pharmaceutical drugs |
| EP1491202A1 (en) | 2003-06-23 | 2004-12-29 | Polichem S.A. | Nail restructuring compositions for topical application |
| US20080069779A1 (en) * | 2003-08-04 | 2008-03-20 | Foamix Ltd. | Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof |
| WO2005028872A2 (en) * | 2003-09-18 | 2005-03-31 | Myrakelle, Llc | Rotary blood pump |
| US20050112151A1 (en) | 2003-11-20 | 2005-05-26 | Horng Liou L. | Skin adherent hydrogels |
| EP1600158A1 (en) * | 2004-05-26 | 2005-11-30 | Galderma Research & Development, S.N.C. | Use of ondansetron for the treatment of inflammation, and pharmaceutical compositions thereof |
| JP2005306746A (ja) | 2004-04-19 | 2005-11-04 | Jiyugaoka Clinic | 顔面用シワ治療剤 |
| US20060024339A1 (en) * | 2004-07-29 | 2006-02-02 | Howard Murad | Methods of managing the redness associated with a dermatological condition |
| ITMI20041567A1 (it) * | 2004-07-30 | 2004-10-30 | Maycos Italiana Di Comini Miro | "derivati n-acilati di acidi bicarbossilici con amminoacidi e con idrolizzati proteici vegetali e loro applicazione in prodotti cosmetici, dermofarmaceutici e farmaceutici" |
| CN1813664A (zh) * | 2005-11-24 | 2006-08-09 | 曾能 | 一种水凝胶美容护肤贴和精华护肤液的制造工艺及产品 |
| BRPI0706661A2 (pt) * | 2006-01-19 | 2011-04-05 | Mary Kay Inc. | composições compreendendo extrato da ameixa kakadu ou extrato da polpa do açaì |
| JP4866173B2 (ja) * | 2006-01-25 | 2012-02-01 | 大日精化工業株式会社 | ヒドロキシアルキル化キトサン溶液 |
| US20110135742A1 (en) * | 2006-06-20 | 2011-06-09 | The Regents Of The University Of California | Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles |
| WO2008038147A2 (en) * | 2006-07-05 | 2008-04-03 | Foamix Ltd. | Foamable vehicle comprising dicarboxylic acid or dicarboxylic acid ester and pharmaceutical compositions thereof |
| EP1958613A1 (en) * | 2007-02-15 | 2008-08-20 | Polichem S.A. | Dermal film-forming liquid formulations for drug release to skin |
-
2008
- 2008-08-05 EP EP08161799A patent/EP2116237A1/en not_active Withdrawn
-
2009
- 2009-07-28 HU HUE09761818A patent/HUE031171T2/hu unknown
- 2009-07-28 KR KR1020117003219A patent/KR101623375B1/ko not_active Expired - Fee Related
- 2009-07-28 SI SI200931556A patent/SI2306999T1/sl unknown
- 2009-07-28 AU AU2009256524A patent/AU2009256524B2/en active Active
- 2009-07-28 MX MX2011001369A patent/MX2011001369A/es active IP Right Grant
- 2009-07-28 HR HRP20161594TT patent/HRP20161594T1/hr unknown
- 2009-07-28 JP JP2011521529A patent/JP5646477B2/ja not_active Expired - Fee Related
- 2009-07-28 EA EA201100243A patent/EA020417B1/ru not_active IP Right Cessation
- 2009-07-28 CA CA2731138A patent/CA2731138C/en active Active
- 2009-07-28 RS RS20161068A patent/RS55507B1/sr unknown
- 2009-07-28 WO PCT/EP2009/059749 patent/WO2009150257A2/en not_active Ceased
- 2009-07-28 DK DK09761818.5T patent/DK2306999T3/en active
- 2009-07-28 PL PL09761818T patent/PL2306999T3/pl unknown
- 2009-07-28 CN CN2009801293276A patent/CN102105142B/zh not_active Expired - Fee Related
- 2009-07-28 ES ES09761818.5T patent/ES2606233T3/es active Active
- 2009-07-28 PE PE2011000059A patent/PE20110564A1/es not_active Application Discontinuation
- 2009-07-28 BR BRPI0917584A patent/BRPI0917584B8/pt active IP Right Grant
- 2009-07-28 NZ NZ590800A patent/NZ590800A/xx not_active IP Right Cessation
- 2009-07-28 EP EP09761818.5A patent/EP2306999B1/en active Active
- 2009-07-28 PT PT97618185T patent/PT2306999T/pt unknown
- 2009-07-28 LT LTEP09761818.5T patent/LT2306999T/lt unknown
- 2009-08-05 AR ARP090103001A patent/AR072917A1/es not_active Application Discontinuation
-
2011
- 2011-01-13 ZA ZA2011/00350A patent/ZA201100350B/en unknown
- 2011-01-17 IL IL210695A patent/IL210695A/en active IP Right Grant
- 2011-01-27 CL CL2011000174A patent/CL2011000174A1/es unknown
- 2011-02-02 US US12/931,486 patent/US9034845B2/en active Active
-
2016
- 2016-11-08 SM SM201600403T patent/SMT201600403B/it unknown
- 2016-11-28 CY CY20161101230T patent/CY1118256T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008543854A5 (cg-RX-API-DMAC7.html) | ||
| JP2008509166A5 (cg-RX-API-DMAC7.html) | ||
| JP2011529936A5 (cg-RX-API-DMAC7.html) | ||
| JP2010077141A5 (cg-RX-API-DMAC7.html) | ||
| RU2017120177A (ru) | Производные аминокислот и их использование | |
| MA31801B1 (fr) | Derives de 1,2,3-triazole destines a etre utilises comme inhibiteurs de la stearoyl-coa desaturase | |
| JP2009544665A5 (cg-RX-API-DMAC7.html) | ||
| EP4293009A3 (en) | Fenfluramine compositions and methods of preparing the same | |
| JP2013518056A5 (cg-RX-API-DMAC7.html) | ||
| JP2012144490A (ja) | 外用組成物 | |
| JP2011503167A5 (cg-RX-API-DMAC7.html) | ||
| SE0402762D0 (sv) | Indazole sulphonamide derivatives | |
| MX2009011554A (es) | Preparacion solida estable conteniendo un derivado de 4,5-epoximorfinano. | |
| FI3817751T3 (fi) | Vedettömän natriumtiosulfaatin formulaatioita | |
| EA200971087A1 (ru) | Фармацевтические композиции и способ лечения острой мании | |
| JP2012508256A5 (cg-RX-API-DMAC7.html) | ||
| CY1116274T1 (el) | Παραγωγο τριαζολιου για χρηση στη θεραπεια του νευροπαθητικου πονου και της ινομυαλγιας | |
| JP2017516770A5 (cg-RX-API-DMAC7.html) | ||
| RU2008110644A (ru) | Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств | |
| JP2014517848A5 (cg-RX-API-DMAC7.html) | ||
| FI3506900T3 (fi) | Ampreloksetiini käytettäväksi neurogeenisen ortostaattisen hypotension | |
| SA520411881B1 (ar) | صياغات إطلاق مديد لتطبيقات داخل المفصل | |
| HRP20161594T1 (hr) | Pripravci za liječenje rozaceje koji sadrže kitozan i amid dikarboksilne kiseline | |
| JP2004534073A5 (cg-RX-API-DMAC7.html) | ||
| EA201000701A1 (ru) | 4-[4-(2-адамантилкарбамоил)-5-трет-бутилпиразол-1-ил]бензойная кислота-465 |